F-18 FDG PET/CT in NK/T-Cell Lymphoma That Progressed from Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis

Overview

Journal Nucl Med Mol Imaging

Publisher Springer

Date 2022 Feb 21

PMID 35186160

Authors

Il-Hyun Kim

Young-Sil An

Su Jin Lee

Joon-Kee Yoon

Affiliations

Soon will be listed here.

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a syndrome involving an uncontrolled immune response with variable triggers. HLH is rare but highly fatal, even with proper treatment; therefore, early recognition and diagnosis are crucial for management. Although the role of F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in HLH is poorly defined, it can provide valuable information on disease status and possible triggers. Herein, we report an F-18 FDG PET/CT study on a case of NK/T-cell lymphoma that progressed from Epstein-Barr virus-associated HLH.

References

Kim J, Yoo S, Kang S, Bom H, Song H, Min J . Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis. Ann Hematol. 2013; 93(4):661-7. DOI: 10.1007/s00277-013-1906-y. View

Henter J, Horne A, Arico M, Egeler R, Filipovich A, Imashuku S . HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2006; 48(2):124-31. DOI: 10.1002/pbc.21039. View

Chen J, Lin K, Lin D, Chen R, Jou S, Su I . Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-containing regimens. Br J Haematol. 1998; 103(3):756-62. DOI: 10.1046/j.1365-2141.1998.01026.x. View

Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian D, Alavi A . Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2008; 39(1):36-51. DOI: 10.1053/j.semnuclmed.2008.08.004. View

Wang J, Wang D, Zhang Q, Duan L, Tian T, Zhang X . The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable. J Cancer Res Clin Oncol. 2015; 142(4):859-71. PMC: 4791461. DOI: 10.1007/s00432-015-2094-z. View

Chuang H, Lay J, Hsieh W, Su I . Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Sci. 2007; 98(9):1281-7. PMC: 11159308. DOI: 10.1111/j.1349-7006.2007.00549.x. View

Yuan L, Kan Y, Meeks J, Ma D, Yang J . 18F-FDG PET/CT for identifying the potential causes and extent of secondary hemophagocytic lymphohistiocytosis. Diagn Interv Radiol. 2016; 22(5):471-5. PMC: 5019854. DOI: 10.5152/dir.2016.15226. View

Zheng Y, Hu G, Liu Y, Ma Y, Dang Y, Li F . The role of F-FDG PET/CT in the management of patients with secondary haemophagocytic lymphohistiocytosis. Clin Radiol. 2016; 71(12):1248-1254. DOI: 10.1016/j.crad.2016.05.011. View

Jordan M, Allen C, Greenberg J, Henry M, Hermiston M, Kumar A . Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019; 66(11):e27929. PMC: 7340087. DOI: 10.1002/pbc.27929. View

10.

Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta M, Bosch X . Adult haemophagocytic syndrome. Lancet. 2013; 383(9927):1503-1516. DOI: 10.1016/S0140-6736(13)61048-X. View